Andropause: Invention, prevention, rejuvenation

Trends in Endocrinology and Metabolism

Volumn 16, Issue 2, 2005, Pages 39-45

  Handelsman, David J ^a   Liu, Peter Y ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; FINASTERIDE; TESTOSTERONE; TESTOSTERONE ENANTATE; TRESTOLONE;

AGING; ANDROGEN DEFICIENCY; ANDROGEN THERAPY; ANDROPAUSE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DEPRESSION; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; ERECTILE DYSFUNCTION; GENETIC RISK; HUMAN; HYPOMANIA; MALE FERTILITY; MALE INFERTILITY; MOOD; MOOD DISORDER; POLYCYTHEMIA; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE DISEASE; REJUVENATION; REPRODUCTIVE HEALTH; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; SIDE EFFECT; SLEEP APNEA SYNDROME; SLEEP DISORDER; SPERMATOGENESIS;

EID: 13944266300     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tem.2005.01.002     Document Type: Article

References (100)

1. World Health Organization Monitoring Reproductive Health: Selecting a Short List of National and Global Indicators 1999 World Health Organization
2. S. Bhasin Managing the risks of prostate disease during testosterone replacement therapy in older men: recommendations for a standardized monitoring plan J. Androl. 24 2003 299 311
3. Liverman, C.T. and Blazer, D.G., eds (2004) Testosterone and Aging: Clinical Research Directions, Institute of Medicine, The National Academies Press
4. C.D. Holman Population-based outcomes after 28,246 in-hospital vasectomies and 1,902 vasovasostomies in Western Australia BJU Int. 86 2000 1043 1049
5. G.P. Mineau, and J. Trussell A specification of marital fertility by parents' age, age at marriage and marital duration Demography 19 1982 335 350
6. B.A. Anderson Male age and fertility: results from Ireland prior to 1911 Popul. Index 41 1975 561 567
7. N. Goldman, and M. Montgomery Fecundability and husband's age Soc. Biol. 36 1989 146 166
8. W.C. Ford Increasing paternal age is associated with delayed conception in a large population of fertile couples: evidence for declining fecundity in older men. The ALSPAC Study Team (Avon Longitudinal Study of Pregnancy and Childhood) Hum. Reprod. 15 2000 1703 1708
9. M.A. Hassan, and S.R. Killick Effect of male age on fertility: evidence for the decline in male fertility with increasing age Fertil. Steril. 79 Suppl. 3 2003 1520 1527
10. M. Sallmen, and R. Luukkonen Is the observed association between increasing paternal age and delayed conception an artefact? Hum. Reprod. 16 2001 2027 2028
11. B.A. Cohn Epidemiologic studies of human semen quality: considerations for study design Am. J. Epidemiol. 155 2002 664 671
12. D.J. Handelsman Sperm output of healthy men in Australia: magnitude of bias due to self-selected volunteers Hum. Reprod. 12 1997 2701 2705
13. S.A. Kidd Effects of male age on semen quality and fertility: a review of the literature Fertil. Steril. 75 2001 237 248
14. K.K. Ng Sperm output of older men Hum. Reprod. 19 2004 1811 1815
15. D.J. Handelsman, and S. Staraj Testicular size: the effects of aging, malnutrition and illness J. Androl. 6 1985 144 151
16. L. Johnson Spermatogenesis and aging in the human J. Androl. 7 1986 331 354
17. E. Nieschlag Reproductive function in young fathers and grandfathers J. Clin. Endocrinol. Metab. 55 1982 676 681
18. T.K. Jensen Association of in utero exposure to maternal smoking with reduced semen quality and testis size in adulthood: a cross-sectional study of 1,770 young men from the general population in five European countries Am. J. Epidemiol. 159 2004 49 58
19. M. Holm Microcalcifications and carcinoma in situ of the testis BJU Int. 87 2001 144 149
20. B. Kuhnert, and E. Nieschlag Reproductive functions of the ageing male Hum. Reprod. Update 10 2004 327 339
21. P.Y. Liu, and D.J. Handelsman The present and future state of hormonal treatment for male infertility Hum. Reprod. Update 9 2003 9 23
22. A. Salonia Pathophysiology of erectile dysfunction Int. J. Androl. 26 2003 129 136
23. P.Y. Liu Androgens and cardiovascular disease Endocr. Rev. 24 2003 313 340
24. A.J. McDougall, and J.G. McLeod Autonomic neuropathy. I. Clinical features, investigation, pathophysiology, and treatment J. Neurol. Sci. 137 1996 79 88
25. F. Buena Sexual function does not change when serum testosterone levels are pharmacologically varied within the normal male range Fertil. Steril. 59 1993 1118 1123
26. C.J. Bagatell Effects of endogenous testosterone and estradiol on sexual behaviour in normal young men J. Clin. Endocrinol. Metab. 78 1994 711 716
27. R. Shabsigh Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone J. Urol. 172 2004 658 663
28. M.D. Altschule, and K.J. Tillotson The use of testosterone in the treatment of depressions N. Engl. J. Med. 239 1948 1036 1038
29. S.N. Seidman Low testosterone levels in elderly men with dysthymic disorder Am. J. Psychiatry 159 2002 456 459
30. A.J. Cussons Brown-Sequard revisited: a lesson from history on the placebo effect of androgen treatment Med. J. Aust. 177 2002 678 679
31. D. Wyndham Versemaking and lovemaking - W.B. Yeats' "Strange Second Puberty": Norman Haire and the Steinach rejuvenation operation J. Hist. Behav. Sci. 39 2003 25 50
32. M. Zitzmann, and E. Nieschlag Hormone substitution in male hypogonadism Mol. Cell. Endocrinol. 161 2000 73 88
33. A.D. Mooradian Biological actions of androgens Endocr. Rev. 8 1987 1 28
34. S.M. Harman Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging J. Clin. Endocrinol. Metab. 86 2001 724 731
35. H.A. Feldman Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts Male Aging Study J. Clin. Endocrinol. Metab. 87 2002 589 598
36. S. Santavirta Determinants of osteoporotic thoracic vertebral fracture. Screening of 57,000 Finnish women and men Acta Orthop. Scand. 63 1992 198 202
37. T.V. Nguyen Risk factors for osteoporotic fractures in elderly men Am. J. Epidemiol. 144 1996 255 263
38. T. Rantanen Grip strength changes over 27 yr in Japanese-American men J. Appl. Physiol. 85 1998 2047 2053
39. V.A. Hughes Longitudinal changes in body composition in older men and women: role of body weight change and physical activity Am. J. Clin. Nutr. 76 2002 473 481
40. Anonymous Incidence of vertebral fracture in Europe: results from the European Prospective Osteoporosis Study (EPOS) J. Bone Miner. Res. 17 2002 716 724
41. J.S. Tenover Effects of testosterone supplementation in the aging male J. Clin. Endocrinol. Metab. 75 1992 1092 1098
42. R. Sih Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial J. Clin. Endocrinol. Metab. 82 1997 1661 1667
43. J.E. Clague Difficulties in measuring the effect of testosterone replacement therapy on muscle function in older men Int. J. Androl. 22 1999 261 265
44. P.J. Snyder Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age J. Clin. Endocrinol. Metab. 84 1999 2647 2653
45. A.M. Kenny Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels J. Gerontol. A Biol. Sci. Med. Sci. 56 2001 M266 M272
46. L.P. Ly A double-blind, placebo-controlled, randomized clinical trial of transdermal dihydrotestosterone gel on muscular strength, mobility, and quality of life in older men with partial androgen deficiency J. Clin. Endocrinol. Metab. 86 2001 4078 4088
47. A.A. Ferrando Testosterone administration to older men improves muscle function: molecular and physiological mechanisms Am. J. Physiol. Endocrinol. Metab. 282 2002 E601 E607
48. P.Y. Liu A double-blind, placebo-controlled, randomized clinical trial of recombinant human chorionic gonadotropin on muscle strength and physical function and activity in older men with partial age-related androgen deficiency J. Clin. Endocrinol. Metab. 87 2002 3125 3135
49. S. Bhasin Androgen effects on body composition Growth Horm. IGF Res. 13 2003 S63 S71
50. S. Bhasin The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men N. Engl. J. Med. 335 1996 1 7
51. R.K. Stellato Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts Male Aging Study Diabetes Care 23 2000 490 494
52. S.M. Haffner Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men. MRFIT Research Group. Multiple Risk Factor Intervention Trial Am. J. Epidemiol. 143 1996 889 897
53. G. Tibblin The pituitary-gonadal axis and health in elderly men: a study of men born in 1913 Diabetes 45 1996 1605 1609
54. J.C. Lovejoy Oral anabolic steroid treatment, but not parenteral androgen treatment, decreases abdominal fat in obese, older men Int. J. Obes. 19 1995 614 624
55. P. Marin The effects of testosterone treatment on body composition and metabolism in middle-aged obese men Int. J. Obes. 16 1992 991 997
56. A.B. Singh The effects of varying doses of T on insulin sensitivity, plasma lipids, apolipoproteins, and C-reactive protein in healthy young men J. Clin. Endocrinol. Metab. 87 2002 136 143
57. C.J. Hobbs Nandrolone, a 19-nortestosterone, enhances insulin-independent glucose uptake in normal men J. Clin. Endocrinol. Metab. 81 1996 1582 1585
58. R.J. Saad Dihydrotestosterone treatment in adolescents with delayed puberty: does it explain insulin resistance of puberty? J. Clin. Endocrinol. Metab. 86 2001 4881 4886
59. P.Y. Liu Do reproductive hormones modify insulin sensitivity and metabolism in older men? A randomized, placebo-controlled clinical trial of recombinant human chorionic gonadotropin Eur. J. Endocrinol. 148 2003 55 66
60. P.J. Snyder Effect of testosterone treatment on bone mineral density in men over 65 years of age J. Clin. Endocrinol. Metab. 84 1999 1966 1972
61. J.K. Amory Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone J. Clin. Endocrinol. Metab. 89 2004 503 510
62. S. Khosla, and B.L. Riggs Androgens, estrogens, and bone turnover in men J. Clin. Endocrinol. Metab. 88 2003 2352
63. A.M. Matsumoto The long-term effect of specific type II 5α-reductase inhibition with finasteride on bone mineral density in men: results of a 4-year placebo controlled trial J. Urol. 167 2002 2105 2108
64. E.M. Frade Costa Normal bone density in male pseudohermaphroditism due to 5α-reductase 2 deficiency Revista do Hospital das Clínicas 56 2001 139 142
65. S. Issa Human osteoblast-like cells express predominantly steroid 5α-reductase type 1 J. Clin. Endocrinol. Metab. 87 2002 5401 5407
66. R.A. Anderson Evidence for tissue selectivity of the synthetic androgen 7α-methyl-19-nortestosterone in hypogonadal men J. Clin. Endocrinol. Metab. 88 2003 2784 2793
67. H.M. Behre Long-term effect of testosterone therapy on bone mineral density in hypogonadal men J. Clin. Endocrinol. Metab. 82 1997 2386 2390
68. A. Falahati-Nini Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men J. Clin. Invest. 106 2000 1553 1560
69. B.A. Crawford Randomised, placebo-controlled trial of androgen effects on bone and muscle in men requiring long-term systemic glucocorticoid therapy J. Clin. Endocrinol. Metab. 88 2003 3167 3176
70. B.Z. Leder Differential effects of androgens and estrogens on bone turnover in normal men J. Clin. Endocrinol. Metab. 88 2003 204 210
71. C. Meier Recombinant human chorionic gonadotropin but not dihydrotestosterone alone stimulates osteoblastic collagen synthesis in older men with partial age-related androgen deficiency J. Clin. Endocrinol. Metab. 89 2004 3033 3041
72. D.J. Handelsman The safety of androgens: prostate and cardiovascular disease C. Wang Male Reproductive Function 1998 Kluwer Academic Publishers 173 190
73. P.J. Snyder Hypogonadism in elderly men - what to do until the evidence comes N. Engl. J. Med. 350 2004 440 442
74. T. Shaneyfelt Hormonal predictors of prostate cancer: a meta-analysis J. Clin. Oncol. 18 2000 847 853
75. S. Slater, and R.T. Oliver Testosterone: its role in development of prostate cancer and potential risk from use as hormone replacement therapy Drugs Aging 17 2000 431 439
76. L. Holmberg A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer N. Engl. J. Med. 347 2002 781 789
77. P.C. Walsh Surgery and the reduction of mortality from prostate cancer N. Engl. J. Med. 347 2002 839 840
78. H.J. de Koning Prostate cancer mortality reduction by screening: power and time frame with complete enrollment in the European Randomised Screening for Prostate Cancer (ERSPC) trial Int. J. Cancer 98 2002 268 273
79. I.M. Thompson The influence of finasteride on the development of prostate cancer N. Engl. J. Med. 349 2003 215 224
80. D. Yin Pharmacodynamics of selective androgen receptor modulators (SARMs) J. Pharmacol. Exp. Ther. 304 2003 1334 1340
81. K. Sundaram, and N. Kumar 7α-methyl-19-nortestosterone (MENT): the optimal androgen for male contraception and replacement therapy Int. J. Androl. 23 Suppl. 2 2000 13 15
82. J.T. Dalton Discovery of nonsteroidal androgens Biochem. Biophys. Res. Commun. 244 1998 1 4
83. A.K. Death Tetrahydrogestrinone is a potent androgen and progestin J. Clin. Endocrinol. Metab. 89 2004 2498 2500
84. D.J. Handelsman Designer androgens in sport: when too much is never enough Sci STKE 2004 pe41
85. F.C. Wu, and A. von Eckardstein Androgens and coronary artery disease Endocr. Rev. 24 2003 183 217
86. S.N. Seidman Testosterone replacement therapy for hypogonadal men with major depressive disorder: a randomized, placebo-controlled clinical trial J. Clin. Psychiatry 62 2001 406 412
87. P.J. Schmidt The effects of pharmacologically induced hypogonadism on mood in healthy men Arch. Gen. Psychiatry 61 2004 997 1004
88. C. Wang Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men J. Clin. Endocrinol. Metab. 89 2004 2085 2098
89. P.Y. Liu The short-term effects of high dose testosterone on sleep, breathing and function in older men J. Clin. Endocrinol. Metab. 88 2003 3605 3613
90. F. Jockenhövel Effects of various modes of androgen substitution therapy on erythropoiesis Eur. J. Med. Res. 2 1997 293 298
91. H.G. Pope Jr Effects of supraphysiologic doses of testosterone on mood and aggression in normal men: a randomized controlled trial Arch. Gen. Psychiatry 57 2000 133 140
92. M. Zitzmann, and E. Nieschlag The CAG repeat polymorphism within the androgen receptor gene and maleness Int. J. Androl. 26 2003 76 83
93. D.J. Handelsman Trends and regional differences in testosterone prescribing in Australia, 1991-2001 Med. J. Aust. 181 2004 419 422
94. A.J. Conway Use, misuse and abuse of androgens: The Endocrine Society of Australia consensus guidelines for androgen prescribing Med. J. Aust. 172 2000 220 224
95. American Association of Clinical Endocrinologists American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients - 2002 update Endocr. Pract. 8 2002 440 456
96. Groopman, J. (2002) Hormones for men. The New Yorker 29 July, 34-38
97. J. Taieb Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children Clin. Chem. 49 2003 1381 1395
98. C. Wang Measurement of total serum testosterone in adult men: comparison of current laboratory methods versus liquid chromatography-tandem mass spectrometry J. Clin. Endocrinol. Metab. 89 2004 534 543
99. D.A. Herold, and R.L. Fitzgerald Immunoassays for testosterone in women: better than a guess? Clin. Chem. 49 2003 1250 1251
100. A.M. Matsumoto, and W.J. Bremner Serum testosterone assays - accuracy matters J. Clin. Endocrinol. Metab. 89 2004 520 524